1. Pathway Targets to Explore in the Treatment of Small Cell and Large Cell Lung Cancers 
Anoor Paripati, MBBS, Chris Kingsley, PhD, Glen J. Weiss, MD 
Journal of Thoracic Oncology 
Volume 4, Issue 11, Pages (November 2009)
DOI: /JTO.0b013e3181ba20cf
Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

2. FIGURE 1
Amyotrophic Lateral Sclerosis Signaling pathway and potential targeting drugs This illustration details the interactions of targets with the potential targeting agents (ellipse with Rx followed by drug name) connected by solid line(s). Additional proteins and targets in this pathway (for which no current drug has been identified) are depicted. Types of interaction relationships are annotated in the figure. Additional drugs for targets are annotated in Supplementary Table 1 (Supplemental Digital Content 2, Data were analyzed through the use of Ingenuity Pathways Analysis (Ingenuity® Systems, and printed with permission.
Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181ba20cf)
Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

3. FIGURE 2
Cell cycle: G2/M DNA Damage Checkpoint Regulation pathway and potential targeting drugs This illustration details the interactions of targets with the potential targeting agents (ellipse with Rx followed by drug name) connected by solid line(s). Additional proteins and targets in this pathway (for which no current drug has been identified) are depicted. Types of interaction relationships are annotated in the figure. Additional drugs for targets are annotated in Supplementary Table 2 (Supplemental Digital Content 2, Data were analyzed through the use of Ingenuity Pathways Analysis (Ingenuity® Systems, and printed with permission.
Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181ba20cf)
Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

4. FIGURE 3
p53 Signaling pathway and potential targeting drugs This illustration details the interactions of targets with the potential targeting agents (ellipse with Rx followed by drug name) connected by solid line(s). Additional proteins and targets in this pathway (for which no current drug has been identified) are depicted. Types of interaction relationships are annotated in the figure. Additional drugs for targets are annotated in Supplementary Table 5 (Supplemental Digital Content 2, Data were analyzed through the use of Ingenuity Pathways Analysis (Ingenuity® Systems, and printed with permission.
Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181ba20cf)
Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

5. FIGURE 4
Wnt/β-Catenin Signaling pathway and potential targeting drugs This illustration details the interactions of targets with the potential targeting agents (ellipse with Rx followed by drug name) connected by solid line(s). Additional proteins and targets in this pathway (for which no current drug has been identified) are depicted. Types of interaction relationships are annotated in the figure. Additional drugs for targets are annotated in Supplementary Table 6 (Supplemental Digital Content 2, Data were analyzed through the use of Ingenuity Pathways Analysis (Ingenuity® Systems, and printed with permission.
Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181ba20cf)
Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions